Federation des caisses Desjardins du Quebec’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$476 Hold
400
﹤0.01% 2580
2025
Q1
$812 Hold
400
﹤0.01% 2442
2024
Q4
$2.41K Hold
400
﹤0.01% 2209
2024
Q3
$2.8K Hold
400
﹤0.01% 2184
2024
Q2
$2.32K Buy
+400
New +$2.32K ﹤0.01% 2088